Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis DOI Creative Commons

Wei Sheng,

Guang Ji, Li Zhang

et al.

Frontiers in Immunology, Journal Year: 2022, Volume and Issue: 13

Published: Dec. 15, 2022

Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD), and dysregulation lipid metabolism oxidative stress are typical features. Subsequent dyslipidemia oxygen radical production may render formation modified lipids. Macrophage scavenger receptor 1 (MSR1) responsible for uptake lipoprotein one key molecules in atherosclerosis. However, unrestricted lipoproteins by MSR1 cholesterol-rich foamy macrophages also can be observed NASH patients mouse models. In this review, we highlight NASH, alteration expression physiological pathological conditions, lipoproteins, role on macrophage foaming development progression.

Language: Английский

Investigating the Hepatic Response to Orlistat and White Tea in Rats on a High-Fat Diet DOI Creative Commons
Serpil Çiftel, Aleksandra Klisić,

Enver Çiftel

et al.

Life, Journal Year: 2024, Volume and Issue: 14(10), P. 1283 - 1283

Published: Oct. 10, 2024

High-fat diets have detrimental health impacts that increase the likelihood of developing obesity and metabolic syndrome. This study aimed to examine potential antioxidant anti-inflammatory effects orlistat white tea in rats fed a high-fat diet. Thirty-two were randomized into four groups: control (standard diet), HFD (high-fat HFD+Orlistat diet+orlistat), HFD+WT diet+white extract). A significant malondialdehyde (MDA) levels decrease total thiol (TT) detected group (

Language: Английский

Citations

2

Co‐Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity‐Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect DOI Creative Commons

S. Melini,

Claudio Pirozzi, Adriano Lama

et al.

Phytotherapy Research, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 30, 2024

ABSTRACT Metabolic dysfunction‐associated fatty liver disease (MAFLD) and diabesity (diabetes related to obesity) are interrelated since glucose lipid alterations play a vital role in the development of both disorders. Due their multi‐variant metabolic features, more than one drug or natural product may be required achieve proper therapeutic effects. This study aimed evaluate effectiveness formulation containing co‐micronized palmitoylethanolamide rutin (PEA‐Rut) associated with hydroxytyrosol (HT), namely NORM3, against hepatic damage high‐fat diet (HFD)‐induced mice. NORM3 decreased body weight fat mass obese The improved HFD‐altered insulin sensitivity production metabolism, as shown by glucose, insulin, pyruvate tolerance tests, Western blot, real‐time PCR. In liver, limited macro‐ micro‐vacuolar steatosis, revealed morphological analysis, reduced inflammation. counteracted dysfunctions HFD animals, activating AMPK, key cellular energy sensor, normalizing expression carnitine palmitoyl‐transferase (CPT)1, rate‐limiting enzyme acid β‐oxidation, other genes involved homeostasis. Relevantly, antioxidant activity was proved (reduced ROS increased detoxifying factors enzymes). Finally, vitro synergistic protective effects components (PEA‐Rut HT) on H 2 O ‐induced oxidative challenge HepG2 were determined (ROS production, inflammation, defense). Our results show beneficial effect its potential an innovative phytotherapeutic combination limiting progression counteracting dysmetabolism diabesity.

Language: Английский

Citations

2

Synthesis, characterization and hepatoprotective effect of silymarin phytosome nanoparticles on ethanol-induced hepatotoxicity in rats DOI Creative Commons
Arezoo Gohari Mahmoudabad, Fatemeh Gheybi, Mohsen Mehrabi

et al.

Bioimpacts, Journal Year: 2023, Volume and Issue: 13(4), P. 301 - 311

Published: May 30, 2023

Silymarin proved to be a beneficial herbal medicine against many hepatic disorders such as alcoholic liver disease (ALD). However, its application is restricted due low bioavailability and consequently decreased efficacy. We herein used nano-based approach known "phytosome", improve silymarin increase efficacy.Phytosome nanoparticles (NPs) were synthesized using thin film hydration method. NPs size, electrical charge, morphology, stability, molecular interaction, entrapment efficiency (EE %) loading capacity (LC determined. Moreover, in vitro toxicity of was investigated on mesenchymal stem cells (MSCs) viability MTT assay. In vivo experiments performed 24 adult rats that divided into four groups including control, ethanol (EtOH) treatment, silymarin/EtOH treatment phytosome/EtOH, with 6 mice each group. Experimental given 40% EtOH, (50 mg/kg) phytosome (200 through the gastric gavage once day for 3 weeks. Biochemical parameters, containing ALP, ALT, AST, GGT, GPx MDA measured before after experiment investigate protective effect phytosomal form. And histopathological examination done evaluate pathological changes.Silymarin mean size 100 nm produced well tolerated cell culture. These showed considerable ALD inverting biochemical parameters (ALP, GPx) alterations.Silymarin can an efficient ALD.

Language: Английский

Citations

6

Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models DOI

Panwen Liu,

Chenkang Wang,

Wenhui Chen

et al.

Phytomedicine, Journal Year: 2022, Volume and Issue: 109, P. 154594 - 154594

Published: Dec. 10, 2022

Language: Английский

Citations

10

Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis DOI Creative Commons

Wei Sheng,

Guang Ji, Li Zhang

et al.

Frontiers in Immunology, Journal Year: 2022, Volume and Issue: 13

Published: Dec. 15, 2022

Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD), and dysregulation lipid metabolism oxidative stress are typical features. Subsequent dyslipidemia oxygen radical production may render formation modified lipids. Macrophage scavenger receptor 1 (MSR1) responsible for uptake lipoprotein one key molecules in atherosclerosis. However, unrestricted lipoproteins by MSR1 cholesterol-rich foamy macrophages also can be observed NASH patients mouse models. In this review, we highlight NASH, alteration expression physiological pathological conditions, lipoproteins, role on macrophage foaming development progression.

Language: Английский

Citations

9